Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial
暂无分享,去创建一个
[1] S. Esmann,et al. Patients' perceptions of topical treatments of actinic keratosis , 2014, The Journal of dermatological treatment.
[2] H. Wulf,et al. Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study , 2014, The British journal of dermatology.
[3] L. Rhodes,et al. Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5‐aminolaevulinic acid photodynamic therapy in human skin , 2013, The British journal of dermatology.
[4] A. Sidoroff,et al. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen’s disease, basal cell carcinoma , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[5] S. Ibbotson,et al. Adverse effects of topical photodynamic therapy , 2011, Photodermatology, photoimmunology & photomedicine.
[6] R. Bissonnette,et al. Photodynamic therapy with methylaminolevulinate 80 mg/g without occlusion improves acne vulgaris. , 2010, Journal of drugs in dermatology : JDD.
[7] J. Q. Rosso,et al. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial , 2010 .
[8] H Abrahamse,et al. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. , 2009, Journal of photochemistry and photobiology. B, Biology.
[9] P. Bjerring,et al. Skin fluorescence controlled photodynamic photorejuvenation (wrinkle reduction) , 2009, Lasers in surgery and medicine.
[10] H. Wulf,et al. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial. , 2008, Archives of dermatology.
[11] H. Wulf,et al. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single‐blinded study , 2008, The British journal of dermatology.
[12] P. Bjerring,et al. 5‐ALA for photodynamic photorejuvenation—optimization of treatment regime based on normal‐skin fluorescence measurements , 2007, Lasers in surgery and medicine.
[13] E. Angell‐Petersen,et al. Phototoxic reaction and porphyrin fluorescence in skin after topical application of methyl aminolaevulinate , 2007, The British journal of dermatology.
[14] L. Rhodes,et al. Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response. , 2006, The Journal of investigative dermatology.
[15] Michael R Hamblin,et al. Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.
[16] Michael R Hamblin,et al. Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. , 2005, Photodiagnosis and photodynamic therapy.
[17] Barbara W. Henderson,et al. Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.
[18] C. Morton. Photodynamic therapy for nonmelanoma skin cancer--and more? , 2004, Archives of dermatology.
[19] H. Wulf,et al. Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. , 2001, The Journal of investigative dermatology.
[20] J. Callen,et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. , 1991, Journal of the American Academy of Dermatology.